616 related articles for article (PubMed ID: 31831046)
1. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
[TBL] [Abstract][Full Text] [Related]
3. Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.
Androuin A; Potier B; Nägerl UV; Cattaert D; Danglot L; Thierry M; Youssef I; Triller A; Duyckaerts C; El Hachimi KH; Dutar P; Delatour B; Marty S
Acta Neuropathol; 2018 Jun; 135(6):839-854. PubMed ID: 29696365
[TBL] [Abstract][Full Text] [Related]
4. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
5. Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease.
Fu AK; Hung KW; Huang H; Gu S; Shen Y; Cheng EY; Ip FC; Huang X; Fu WY; Ip NY
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9959-64. PubMed ID: 24958880
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease.
Pedrazzoli M; Losurdo M; Paolone G; Medelin M; Jaupaj L; Cisterna B; Slanzi A; Malatesta M; Coco S; Buffelli M
Neurobiol Dis; 2019 Dec; 132():104568. PubMed ID: 31394203
[TBL] [Abstract][Full Text] [Related]
7. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers.
Vargas LM; Leal N; Estrada LD; González A; Serrano F; Araya K; Gysling K; Inestrosa NC; Pasquale EB; Alvarez AR
PLoS One; 2014; 9(3):e92309. PubMed ID: 24658113
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine Protects against Dendritic Spine Loss in Middle-aged APPswe/PSEN1dE9 Double Transgenic Alzheimer's Disease Mice.
Ma J; Gao Y; Tang W; Huang W; Tang Y
Curr Alzheimer Res; 2020; 17(1):93-103. PubMed ID: 32053075
[TBL] [Abstract][Full Text] [Related]
10. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
[TBL] [Abstract][Full Text] [Related]
11. A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.
Song JM; DiBattista AM; Sung YM; Ahn JM; Turner RS; Yang J; Pak DT; Lee HK; Hoe HS
Exp Neurol; 2014 Feb; 252():105-13. PubMed ID: 24316432
[TBL] [Abstract][Full Text] [Related]
12. Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
Hollnagel JO; Elzoheiry S; Gorgas K; Kins S; Beretta CA; Kirsch J; Kuhse J; Kann O; Kiss E
PLoS One; 2019; 14(1):e0209228. PubMed ID: 30645585
[TBL] [Abstract][Full Text] [Related]
13. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D
J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617
[TBL] [Abstract][Full Text] [Related]
14. Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.
Lee S; Salazar SV; Cox TO; Strittmatter SM
J Neurosci; 2019 Mar; 39(10):1910-1929. PubMed ID: 30626696
[TBL] [Abstract][Full Text] [Related]
15. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis.
Maiti P; Bowers Z; Bourcier-Schultz A; Morse J; Dunbar GL
Alzheimers Res Ther; 2021 Feb; 13(1):37. PubMed ID: 33557949
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of Na
Moriguchi S; Kita S; Fukaya M; Osanai M; Inagaki R; Sasaki Y; Izumi H; Horie K; Takeda J; Saito T; Sakagami H; Saido TC; Iwamoto T; Fukunaga K
Neuropharmacology; 2018 Mar; 131():291-303. PubMed ID: 29274751
[TBL] [Abstract][Full Text] [Related]
17. Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
Merino-Serrais P; Knafo S; Alonso-Nanclares L; Fernaud-Espinosa I; DeFelipe J
Hippocampus; 2011 Oct; 21(10):1037-44. PubMed ID: 20848609
[TBL] [Abstract][Full Text] [Related]
18. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.
Heiss JK; Barrett J; Yu Z; Haas LT; Kostylev MA; Strittmatter SM
Cereb Cortex; 2017 Jul; 27(7):3660-3674. PubMed ID: 27365298
[TBL] [Abstract][Full Text] [Related]
19. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
